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Abstract: Acquired punctal stenosis is a condition in which the external opening of the lacrimal 
canaliculus is narrowed or occluded. This condition is a rare cause of symptomatic epiphora, 
but its incidence may be higher in patients with chronic blepharitis, in those treated with various 
topical medications, including antihypertensive agents, and especially in patients treated with 
taxanes for cancer. The purpose of this review is to cover the medical literature, focusing in 
particular on definition, incidence, risk factors, etiology and treatment options.
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Introduction
Epiphora is a common complaint encountered by ophthalmologists, with a broad dif-
ferential diagnosis. One of the least discussed etiologies of epiphora is stenosis of the 
external lacrimal punctum. When it occurs, the most common presenting symptom is 
tearing, but patients may have vague complaints of ocular discomfort.1 Stenosis must 
be distinguished from complete occlusion of the puncti, which differs in its treatment 
and prognosis. This review relates only to punctal stenosis.
Anatomically, acquired punctal stenosis is a condition in which the external opening 
of the lacrimal canaliculus, located in the nasal part of the palpebral margin, is narrowed 
or occluded. A complete congenital occlusion of the external punctum is referred to as 
punctal agenesis. Stenosis of the external lacrimal punctum may be accompanied by 
canalicular or common canalicular duct stenosis, either of which may make treatment 
more complicated.2 The goal of this work is to review the medical literature and to 
highlight some of the controversial issues pertaining to punctal stenosis.
Anatomy
The lacrimal puncti are positioned at the medial part of the eyelid margins (Figure 1). 
They open into the tear lake near the plica semilunaris and the bulbar conjunctiva. The 
upper punctum is generally located 0.5–1 mm medial to the lower punctum according 
to the laterally sloped caruncle shape. When the eyelids are closed, these two puncti 
are usually adjacent to one another.
The puncti are located within an elevated structure referred to as the lacrimal papilla. 
They are considered to be 0.2–0.3 mm in diameter and are surrounded by a fibrous 
ring.3 The papillae are surrounded by the muscle of Riolan, and are pulled medially 
and posteriorly by the muscle fibers.4
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The normal anatomy of the punctum varies greatly and there 
is scant evidence to aid in the clinical definition of what 
constitutes punctal stenosis. Textbook parameters for punctal 
diameter range from 0.2 mm to 0.5 mm.3,5–7 A prospective 
study of 50 asymptomatic patients found the lower puncti 
to be significantly larger in diameter than the upper puncti.8 
No difference between genders was found. The mean area 
of the upper puncti was 0.264 ± 0.141 mm2. The mean area 
of the lower puncti was 0.321 ± 0.155 mm2, and the varia-
tion was substantial (0.1–0.7 mm2 for the upper puncti and 
0.1–0.8 mm2 for the lower puncti). Unfortunately, this study 
utilized methods that may be more suitable for research rather 
than in the clinical setting, and did not assess the correlation 
between aperture size and clinical epiphora.
In a prospective study of about 150 patients, the mean 
diameter and area of lower puncti were assessed.9 The mean 
diameter of round-shaped puncti was 0.1 mm, with no gen-
der variation. The mean area was 0.008 mm2 in females and 
0.01 mm2 in males (statistically insignificant). The substantial 
discrepancy between this measurement and that of the previ-
ous study may be explained by a change in assessment modal-
ity, ie, the previous study used photography and software 
analysis, while in the latter, punctal size was assessed directly 
by an observer using a graduated eyepiece. The latter study 
found a statistically significant negative relationship between 
punctal diameter and age in females, and demonstrated that 
patients with closed puncti are older than patients with open 
puncti (P , 0.0001). However, the study failed to examine 
the correlation between epiphora and punctal size.
Other authors define punctal stenosis as a diameter of less 
than 0.3 mm or the inability to intubate the punctum with a 
26 G cannula (outer diameter 0.47 mm) without dilation.10
No randomized, controlled studies have been published 
on the correlation between clinical epiphora and punctal size, 
and so defining a clear cut-off value for punctal stenosis is 
 difficult. Consequently, there are no uniform guidelines defin-
ing what constitutes an indication to treat punctal narrowing. 
The lack of consensus results in nonstandardized clinical 
trials and may affect the clinical decision-making process.
Measurement of punctal size
Several methodologies have been used to measure punctal 
size. One method entails photographing all four puncta by 
slit-lamp biomicroscopy.8 The punctal borders are later 
mapped out using a computer cursor assembly probe and a 
Hi Pad digitalizer. Punctal area is determined by software-
driven computer analysis.
Another method entails use of a Ramsden eyepiece 
which consists of a fixed transparent graduated scale posi-
tioned on the field and fitted to the slit-lamp.9 The fixed 
optical magnification of 32× results in a scale resolution 
of 0.03 mm.
Further potential methods may entail fitting different 
gauge cannulae (20–32 G), but because the punctal walls are 
stretched during intubation, this may not be a good predictor 
of punctal size under normal physiological conditions.
The method used by the authors combines both slit-lamp 
examination to measure punctal size coupled with microruler 
standardized photography of the puncti, allowing objective 
measurement of shape, maximal height, maximal width, and 
mean cross-sectional area.
Incidence
The incidence of punctal stenosis has not been determined in 
any large population-based studies, and the available num-
bers from relatively small studies vary greatly. In a retrospec-
tive chart review at a tertiary referral center in Canada, 8% 
of tearing patients had either punctal stenosis or canalicular 
block.11 Indeed, this study was limited by its retrospective 
nature, its small size (n = 150), and lack of a standardized 
definition of punctal stenosis. Having been conducted in a 
tertiary center, it was also possibly biased. Nevertheless, it 
reported a surprisingly high rate of punctal stenosis compared 
with what was believed in the past.
Figure 1 The puncti are positioned medially, near the medial canthus. They are 
located within the papillae. This complex opens into the tear layer. The tears are 
collected through the puncti and into the canaliculi.






In a prospective study, 682 patients (not necessarily 
symptomatic) referred to a general ophthalmology clinic 
were evaluated for punctal stenosis, defined as a punctum 
visible but smaller than 0.3 mm and requiring probing with 
a punctal finder, followed by a standard punctal dilator, in 
order to insert a 00 Bowman probe.12 Some 54.3% of the 
patients were diagnosed with punctal stenosis. Upper punctal 
stenosis was more common than lower punctal stenosis. The 
strength of this study lies in its relatively large population 
size and its observational nature, following both symptomatic 
and asymptomatic patients. In another study by Kashkouli 
et al, lower punctal stenosis was more common than upper 
punctal stenosis.1
None of the above-mentioned studies addressed the issue 
of the predictive value of epiphora in diagnosing acquired 
punctal stenosis. Therefore, the incidence and prevalence 
of punctal stenosis have yet to be determined, and it is also 
unclear whether a complaint of tearing warrants a meticulous 
search for the condition.
In summary, the incidence of punctal stenosis is still 
unknown, with reported rates ranging from 8% to 54.3%, 
depending on setting, demographics, and probably interob-
server variability. Nevertheless, the literature suggests that 
this pathology should be given special consideration while 
assessing the tearing patient, because it may involve an easier 
surgical solution than in patients with obstruction in the more 
distal lacrimal system.
Risk factors
Differentiating between risk factors and etiological factors in 
this disease is difficult. However, in a prospective study by 
Kashkouli et al old age and female gender were found to be 
risk factors.1 In other prospective studies, age was regarded 
as a risk factor, but there was no gender predilection.8,12 
Chronic blepharitis, apart from its etiological contribution, 
was found to be a risk factor for recurrent stenosis after 
wedge punctoplasty.13
Etiology
Many factors have been implicated in the pathogenesis of 
acquired external punctal stenosis (see Table 1). Old age 
has been identified in several studies as a cause of punctal 
stenosis.1,8,14 The supposed pathogenesis is involutional 
changes involving the external lacrimal punctum leading 
to its narrowing or occlusion. In one study, the mean age at 
diagnosis was 69.4 years.1
Chronic lid inflammation, especially chronic blepharitis, 
remains a widely identified cause of acquired punctal stenosis.1,12 
The pathogenesis suggested is chronic  inflammation of the 
external punctum leading to gradual fibrotic changes in the 
ostium, followed by progressive occlusion of the duct. Dry 
eye syndrome, which may be secondary to chronic blepharitis, 
has also been suggested as an etiological factor.12 Infections 
involving the eyelid, such as trachoma and herpes simplex, 
may also result in stenosis.15,16 Other pathogens implicated are 
chlamydia, actinomyces, and human papilloma virus.10
Longstanding treatment with several topical antiglaucoma 
agents, such as timolol, latanoprost, betaxolol, dipivefrin 
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hydrochloride, echothiophate iodide, and pilocarpine has also 
been associated with punctal stenosis.1,17 Other topical agents 
have also been suggested as causes, and are often adminis-
tered simultaneously. They include prednisolone acetate/
phenylephrine hydrochloride, adrenaline, chloramphenicol, 
tobramycin, indomethacin, dexamethasone, tropicamide, 
naphazoline, and various artificial tear preparations.17 Topical 
administration of mitomycin C for ocular surface neoplasia 
has also been associated with punctal stenosis, but on the 
other hand, it has been suggested as a beneficial adjunct to 
corrective posterior punctectomy.18–20
Systemic medications are also associated with acquired 
punctal stenosis. Chemotherapeutic agents such as 
5-fluorouracil, docetaxel, and paclitaxel have been impli-
cated in the literature.21–27 Idoxuridine is also suspected to 
be a causative agent.28
Eyelid malposition, as seen in ectropion, may cause punc-
tal stenosis, possibly due to underuse of an external punctum 
unopposed to the tear meniscus, or perhaps secondary to local 
inflammation.1,29 Other rare etiologies include peripunctal 
tumors, which are seldom observed in clinical practice.30 
Systemic diseases, such as acrodermatitis enteropathica 
and porphyria cutanea tarda, have also been reported in 
association with punctal stenosis.10,31 Instances of the condi-
tion following local irradiation or photodynamic therapy for 
macular disease have also been described in the literature.10,32 
Ocular cicatricial pemphigoid and graft-versus-host disease 
are further possible etiologies. Eyelid trauma and secondary 
healing could potentially result in stenosis as well.10
Treatment
In general, a few methods are currently used in the manage-
ment of punctal stenosis. The most simple method involves 
use of perforated punctal plugs, which is a reversible pro-
cedure. Minor surgical techniques require incision of the 
puncta and punctoplasty.
Perforated punctal plugs
This procedure is an easily performed intervention, suitable 
for an office setting, in which a perforated punctal plug is 
placed in the external punctum, usually after dilation, and left 
in place for a certain period of time. The underlying rationale 
is longstanding dilation of the punctum, in order to prevent 
the risk of recurrent stenosis that may occur as a result of 
wound healing after punctal snip procedures. However, 
evidence for the efficacy of the procedure is scarce.
In a retrospective series of 44 eyes from 26 patients 
treated with dilation and the placement of a perforated 
punctal plug for acquired punctal stenosis, the success rate 
was 84.1% (37 of 44 eyes) for cessation of epiphora.33 The 
plugs were extracted after 2 months. Most cases had partial 
punctal stenosis. Associated eyelid laxity was detected in 
14 eyes, and eight of them underwent a lateral tarsal strip 
procedure prior to plug implantation. The mean follow-up 
period was 19 months. Failures were due to either restenosis 
or horizontal eyelid laxity.
Although perforated punctal plugs are an attractive non-
surgical tool in the management of acquired punctal stenosis, 
the long-term results of the procedure and its role in treating 
punctal stenosis will have to be determined in future, larger 
clinical trials.
Other stenting procedures
Recent reports have suggested utilizing a mini-Monoka® 
stent (FCI Ophthalmics, Issy-Les-Moulineaux, France) in 
cases of punctal stenosis. This procedure may be more suit-
able for cases of combined punctal and canalicular stenosis. 
Prior to stent placement, dilation alone is performed, rather 
than a one-snip punctoplasty, followed by stenting. This 
method has been shown to reduce the rate of stent  migration.34 
Another retrospective study of 123 eyes, 73% with punctal 
stenosis, 72% with canalicular stenosis, and 46% with a 
combination of the two, has demonstrated a significant 
improvement of symptoms in 82% of eyes undergoing mini-
Monoka punctocanaliculoplasty without a snip procedure. 
The follow-up period was 6 weeks, and so these results may 
not represent long-term success.35
Balloon dilation
The method of balloon dilation has been described for the 
treatment of common canalicular stenosis. One study found 
that over half of treated patients were free of symptoms 
at 9 months following the procedure.36 However, balloon 
dilation of the punctum has not been described in clinical 
studies. Another disadvantage associated with this method 
is patient discomfort. Therefore, the role of this technique in 
the treatment of punctal stenosis is as yet unclear.
Punctal snip procedures
One-snip punctoplasty was initially reported in 1853 by 
 Bowman and was later described in 1873 by Arlit.37,38 The proce-
dure facilitates tear drainage by producing a full-length incision 
along the canaliculus with a canaliculus knife. This procedure 
undoubtedly abolishes the capillary action of the canaliculus. 
After a century, during which the procedure was abandoned 
for other alternatives, it re-emerged with Jones’ single vertical 






snip down the ampulla (Figure 2).39 Failure secondary to wound 
reapproximation was treated with dilation and a subsequent 
two-snip procedure, or with a punch ampullectomy.13,40
Other interventions were later proposed to reduce further 
the risk of reapproximation. Placing the lid under tension with 
a 4-0 suture and anchoring the tarsus to a sterile button was 
contemplated by Dolin and Hecth in 1986.41 In 1993, Lam and 
Tessler suggested topical instillation of mitomycin C as an 
adjunctive treatment.42 In 1993, Offutt and Cowen proposed 
a new approach in which the punctum was removed and the 
vertical canaliculus was externalized.43
Success rates as high as 90% with the three-snip procedure 
(Figure 3) were reported by Caesar and McNabb, but these 
results may not reflect sustained long-term success, because 
the duration of follow-up was not reported.10 Additionally, 
the patients in that study were questioned about epiphora only 
one week after surgery. Some patients may experience a peri-
operative paradoxical epiphora immediately after the procedure 
due to local irritation and inflammation from the procedure 
itself.44 Furthermore, of 102 potential patients, almost half were 
excluded; 22 because of additional surgery and 16 who elected 
not to undergo surgery. A paucity of data exists on patient 
selection, especially with respect to the coexistence of lacrimal 
system obstruction at sites other than the punctum, coexistence 
of dry eye, tear hypersecretion, or lacrimal pump failure.
In a prospective randomized study by Sadiq et al, retro-
punctal cautery and one-snip punctoplasty were compared 
with syringing alone.45 Three months after treatment, the first 
group displayed statistically significant improvement. The 
authors concluded that cautery and one-snip punctoplasty 
should be considered in patients with patent lacrimal systems 
and punctal stenosis. Once again, the study only provided 
short-term (3-month) follow-up data.
In a large retrospective study of 169 patients with appro-
priate preoperative evaluation, two-snip punctoplasty was 
compared with three-snip punctoplasty.46 A two-snip pro-
cedure entails a vertical cut to the medial and lateral wall of 
the punctum, followed by removal of the tissue left between 
the incisions. This last step is accomplished by performing 
a third cut at the base of the tissue bridging the cuts (Figure 4). 
The three-snip punctoplasty involves a vertical cut down the 
ampulla, followed by a horizontal cut along the roof of the 
canaliculus, thus forming a free flap connected to the floor 
of the canaliculus-ampulla complex. Subsequently, the base 
of the flap is incised, leaving a broadened canalicular ostium 
(Figure 3). In this study, 91% of patients achieved anatomical 
success, while 64% achieved functional success. Partial func-
tional success was evident in 14%. Seventy-one percent of the 
patients were satisfied with the results. The data suggest that 
both two-snip and three-snip punctoplasty were satisfactory 
in yielding anatomical success, with 91.1% for the two-snip 
procedure and 94.1% for the three-snip procedure (P = 0.7). 
Accounting only for the cases with anatomical success,  two-snip 
procedures were more likely to achieve functional success Figure 2 Jones’ one-snip punctoplasty. A vertical incision is made along the ampulla.
Figure 3 Three-snip punctoplasty. A vertical incision is made down the ampulla. 
A horizontal incision is then made along the canaliculus. A last incision made along 
the base of the free flap opposing the bulbar conjunctiva creates a triangular-shaped 
broadened punctum.






(71.4% versus 62.5% in the three-snip procedure, P = 0.03). 
The surgeon grade did not seem to affect the rates of anatomi-
cal success (P = 0.4), making this method a suitable surgical 
procedure for surgeons with different skills and experience. 
Postoperative topical steroids did not improve surgical outcome 
(P = 0.7). The mean follow-up duration in this study was 23 
(range 1–208) weeks, and so, once again, it is unclear whether 
the snip procedures provide long-term relief of epiphora.
Another retrospective study of 75 patients with a mean 
follow-up of 0.68 years suggested that rectangular puncto-
plasty (two vertical incisions at either side of the vertical 
canaliculus and one cut at the base) may be more effective 
than the common triangular three-snip procedure.47
Another potential problem is associated canalicular 
stenosis. In one study, up to 45% of patients with acquired 
external punctal stenosis had associated canalicular  stenosis.1 
This may jeopardize the results of punctoplasty alone. To 
address this issue, as well as the problem of punctal rest-
enosis, a one-snip punctoplasty using mini-Monoka tube 
insertion was proposed.2 This procedure has yielded up to 
85% functional success and 96.2% anatomical success at a 
mean follow-up of 18.5 months.
Management of patients treated 
with taxanes
Special attention must be given to patients about to undergo 
treatment with taxanes. In a study by Esmaeli et al it was 
suggested that patients treated with docetaxel be referred 
to an ophthalmologist as soon as they develop epiphora.26 
These investigators also recommended silicone intubation 
and punctoplasty, depending on findings upon probing and 
irrigation of the canaliculi, and depending on the severity of 
symptoms. Punctoplasty alone was considered appropriate 
for patients with punctal stenosis and normal canaliculi who 
have already finished their treatment course with docetaxel. 
Bicanalicular silicone intubation was recommended for 
patients with canalicular stenosis and for those planning 
to continue on docetaxel. A later prospective study by this 
group examined the effect of docetaxel dosing regimens on 
the development of punctal stenosis.48 Epiphora developed 
at a mean duration of 2 months from treatment initiation in 
the patients treated weekly. The group treated every 3 weeks 
developed the condition at a mean interval of 3 months. This 
study has provided evidence that weekly treatment with 
docetaxel may be a risk factor for development of acquired 
punctal stenosis. Sixty-four percent of patients treated weekly 
developed punctal stenosis as compared with approximately 
40% in the group treated every 3 weeks. That study had also 
suggested judicious use of topical corticosteroids, meticu-
lous follow-up, and repeated probing and irrigation (every 
4–6 weeks) as a treatment modality for a subset of patients. 
This regimen makes silicone intubation or other interven-
tions redundant in 80% of the docetaxel group treated every 
3 weeks and in 50% of the group treated every week. Other 
recommendations in patients who fail conservative therapy 
include long-term silicone intubation and implantation of 
silicone lacrimal stents to be left in position during the period 
of docetaxel treatment. Based on these data, we suggest 
screening these patients for signs of epiphora and punctal 
stenosis prior to treatment, and then weekly, starting two 
months after the initiation of treatment.
Conclusion
Punctal stenosis may in fact be a substantial etiological factor 
that should be considered in the assessment and treatment 
of the tearing patient. Lack of consensus as to what consti-
tutes functionally disabling punctal stenosis has resulted in 
significant variability in the definition of the condition in 
research settings. Consequently, there are no uniform clinical 
guidelines for treatment of the disease.
The risk factors for development of acquired punctal 
stenosis are primarily old age and chronic blepharitis, so the 
main treatable risk factor is the latter, although no literature 
currently supports the hypothesis that treatment of chronic 
blepharitis reduces the incidence of acquired punctal stenosis. 
Figure 4 Two-snip punctoplasty. A vertical cut is made in the medial wall of the 
punctum and then in the lateral wall. The flap remaining is incised at its base.






Nevertheless, considering the relative ease of managing this 
condition, we recommend treatment for susceptible patients, 
especially those with an increased risk for developing punctal 
stenosis due to topical or systemic treatment with causative 
medications.
Although perforated punctal plugs and mini-Monoka 
stents are theoretically promising tools in the treatment of 
the disease, clinical studies have yet to demonstrate their 
long-term success. Substantial experience with minor sur-
gical snip procedures would suggest giving preference to 
their utilization in the treatment of the disease. From our 
experience, the one-snip procedure generally does not yield 
long-term success in alleviating symptoms. Therefore, we 
suggest performing a two-snip or three-snip punctoplasty 
when indicated.
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